NeuroDerm

Recent Finacing

Equity

Recent Raise

$16M

NeuroDerm is a clinical-stage pharmaceutical company developing subcutaneous continuous-delivery levodopa/carbidopa (ND0612H, ND0612L) via a belt pump for Parkinson’s disease; ND0612L is in Phase II.